Multimodal Analgesia for Major Skin Grafting Under General Anesthesia
For major skin grafting under general anesthesia, implement a multimodal analgesic regimen consisting of: intravenous acetaminophen (paracetamol) and NSAIDs intraoperatively after graft placement, intravenous dexamethasone 8 mg at induction, ketamine 0.5 mg/kg bolus followed by 0.125-0.25 mg/kg/h infusion (stopped 30 minutes before surgery end), and consider adding gabapentin perioperatively—with strong opioids (morphine or oxycodone) reserved for breakthrough pain via IV-PCA, minimizing total opioid exposure.
Algorithmic Approach
Pre-operative Phase
- Gabapentin: Consider 300-600 mg orally if patient can take medications pre-operatively. Evidence from burn patients undergoing skin grafting shows gabapentin reduces post-operative opioid requirements by approximately 25 mg morphine equivalents 1.
- Oral acetaminophen: 1 gram if time permits before procedure 2.
Intra-operative Phase (After Graft Placement)
Core multimodal components (administer all unless contraindicated):
Dexamethasone 8 mg IV at induction 3
- Reduces postoperative pain and PONV
- Standard adult dose; 0.15 mg/kg in children
Ketamine for high-pain procedures like skin grafting 3
- Bolus: 0.5 mg/kg IV after induction (prevents psychodysleptic effects)
- Infusion: 0.125-0.25 mg/kg/h during surgery
- Stop 30 minutes before surgery end
- Reduces 24-hour morphine consumption by ~15 mg and decreases acute pain intensity
Acetaminophen (Paracetamol) 2
- 1 gram IV (15-20 mg/kg loading dose)
- If not given pre-operatively, administer intraoperatively
- Strong recommendation as baseline for all pain intensities
NSAIDs 2
- Ketorolac 0.5-1 mg/kg IV (max 30 mg single dose) OR
- Ketoprofen 1 mg/kg IV OR
- Ibuprofen 10 mg/kg IV
- Critical caveat: Avoid in patients with cardiovascular disease, bleeding risk, renal impairment, or on therapeutic anticoagulation 3, 4
- Do NOT combine NSAIDs with curative-dose anticoagulants (multiplies bleeding risk by 2.5×) 3
Intravenous lidocaine (if no regional block used) 3
- Bolus: 1-2 mg/kg
- Infusion: 1-2 mg/kg/h
- Provides analgesic, anti-hyperalgesic, and anti-inflammatory effects
Strong opioids: Administer intraoperatively to secure analgesia upon awakening 4
- Use long-acting opioids (morphine or fentanyl)
- Minimize dose through multimodal approach
Post-operative Phase
Scheduled (around-the-clock) medications:
- Acetaminophen: 1 gram PO/IV every 6 hours (max 4 g/day) 2
- NSAIDs: Continue every 8 hours if no contraindications 2
- Ibuprofen 400-600 mg PO every 8 hours OR
- Diclofenac 50-75 mg PO every 8 hours
Breakthrough pain management:
- IV-PCA with morphine (preferred over on-demand or IM administration) 2, 4
- Start with bolus dosing in opioid-naïve patients
- Alternative: Oxycodone PO (oral route preferred when tolerated) 3
- Conversion: 5 mg oxycodone = 10 mg morphine sulfate PO
- IV ratio is 1:1
Transition strategy:
- Shift to oral opioids (morphine or oxycodone) as soon as patient tolerates PO 3
- Continue scheduled acetaminophen + NSAID throughout recovery period
- Wean opioids as pain intensity decreases
Evidence-Based Rationale
The 2022 WSES-GAIS-SIAARTI-AAST guidelines provide the strongest framework, emphasizing that multimodal analgesia should always be considered to improve analgesia while reducing individual class-related side effects 2. This approach uses a pharmacological step-up strategy, adding opioids only when necessary.
Burn-specific evidence from a 2020 study demonstrates that patients receiving the combination of acetaminophen, gabapentin, and ketamine had 47 mg less morphine equivalent increase compared to controls (p=0.010) 1. Most patients (69%) report severe pain (NRS ≥7) immediately after skin grafting, with an average increase of 52 mg oral morphine equivalents needed in the first 24 hours post-procedure 1.
The 2019 French expert panel guidelines reinforce that acetaminophen administered at the beginning of postoperative analgesia may be better and safer than other drugs and that its use in multimodal therapy reduces opiate side effects 3. The combination approach targets different pain pathways: acetaminophen for central sensitization, NSAIDs for peripheral inflammation, ketamine for NMDA-receptor antagonism and anti-hyperalgesia, and gabapentinoids for neuropathic components 2.
Critical Pitfalls to Avoid
NSAID contraindications: Do not use in patients with:
Opioid over-reliance: The guidelines strongly recommend reducing opiate usage as much as possible 2. Use the multimodal foundation first, adding opioids only for breakthrough pain.
Ketamine timing: Administer after induction (not before) to prevent psychodysleptic effects, and stop 30 minutes before surgery end 3. Continuing into the postoperative period increases hallucination risk without significant analgesic benefit.
Monotherapy failure: Paracetamol alone is insufficient—it should only be used in combination with other analgesics 4.
Regional anesthesia consideration: While not specifically addressed in skin grafting guidelines, a 2026 study showed that regional blocks (sciatic popliteal + adductor canal) in lower-limb burn surgery resulted in 84% of patients requiring no or minimal opioids 5. Consider regional techniques when anatomically feasible for donor or graft sites.
Special Populations
Patients with chronic pain or opioid tolerance: Ketamine becomes even more critical in this population 3. Consider higher-end dosing and potentially continuing gabapentinoids beyond the perioperative period.
Elderly or OSAS patients: Minimize opioid use aggressively to prevent cardiopulmonary complications 2. Rely more heavily on the non-opioid multimodal components.
Pediatric patients: Adjust doses appropriately (dexamethasone 0.15 mg/kg, acetaminophen 15-20 mg/kg loading dose, ibuprofen 10 mg/kg) 6.
This evidence-based multimodal approach, anchored in the most recent high-quality guidelines 2, 3, 2, 3 and augmented with procedure-specific research 1, provides superior analgesia while minimizing opioid-related morbidity and improving recovery quality.